Advances in rheumatology practice in Brazil

被引:0
作者
Francisco Airton Castro Rocha
Joaquim Ivo Vasques Dantas Landim
Leila Nascimento da Rocha
机构
[1] Federal University of Ceará,Laboratório de Investigação em Osteoartropatias, Department of Internal Medicine, Liga de Reumatologia e Doenças Autoimunes, Instituto de Biomedicina, Faculdade de Medicina
来源
Rheumatology International | 2019年 / 39卷
关键词
Arthritis; Disease burden; Rheumatology; Epidemiology;
D O I
暂无
中图分类号
学科分类号
摘要
Despite resilient inequities, Brazil has seen progressive improvement in health care in the last 25 years. Infectious diseases rendered place to chronic non-communicable diseases as a major cause of death. Existence of traditional schools of medicine and training services in rheumatology helped form a reasonable number of specialists, though irregular distribution due to the economic issues favoring their clustering in major cities. The Brazilian Society of Rheumatology provides continued medical education, helps training rheumatologists, family physicians and other health professionals and has worked to publish national recommendations for the diagnosis and treatment of major rheumatic diseases. Access to medications and health care facilities is provided for most patients, free of direct charge, including biologics. Specialized services for autoimmune and rare diseases, including pediatric rheumatology and autoinflammatory diseases, have improved, particularly in developed centers of the southern best developed parts of the country. A major unmet need is the lack of access to non-pharmacological treatment modalities. In this article, we will summarize some of the strengths and points that need improvement to enhance access to the rheumatological health care in Brazil.
引用
收藏
页码:1125 / 1134
页数:9
相关论文
共 682 条
[1]  
Smith E(2018)Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016 Lancet 392 760-775
[2]  
Hoy DG(2014)The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study Ann Rheum Dis 73 1462-1469
[3]  
Cross M(2014)Musculoskeletal disorders and the Global Burden of Disease study Ann Rheum Dis 73 949-950
[4]  
Vos T(2017)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Ann Rheum Dis 76 960-977
[5]  
Naghavi M(2015)The health gap: the challenge of an unequal world Lancet 386 2442-2444
[6]  
Buchbinder R(2010)Geoepidemiology of autoimmune rheumatic diseases Nat Rev Rheumatol 6 468-476
[7]  
Woolf AD(2017)Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey Clin Rheumatol 36 485-497
[8]  
March L(2015)Rheumatology in India–quo vadis? Nat Rev Rheumatol 11 183-188
[9]  
Storheim K(2004)Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach J Rheumatol 31 594-597
[10]  
Zwart J-A(2011)Brazilian biologic registry: BiobadaBrasil implementation process and preliminary results Rev Bras Reumatol 51 152-160